Maeve Pascoe

Ms. Maeve Pascoe

Cleveland Clinic Lerner College of Medicine
+1

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
Maeve PascoeMaeve Pascoe
Maeve Pascoe
LCLawrence P. Carter
Lawrence P. Carter
EHEveline Honig
Eveline Honig
JBJames Bena
James Bena
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
Study Objectives:To explore knowledge and experiences of women with narcolepsy on pregnancy and contraception issues and their relationships with narcolepsy pharmacotherapy.Methods:An 18-item surve...

1 August 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
NSNiratchada Sap-Anan
Niratchada Sap-Anan
Maeve PascoeMaeve Pascoe
Maeve Pascoe
LWLu Wang
Lu Wang
MGMadeleine M. Grigg-Damberger
Madeleine M. Grigg-Damberger
NANoah D. Andrews
Noah D. Andrews
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer

15 November 2019 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
HWHarneet Walia
Harneet Walia
NTNicolas R. Thompson
Nicolas R. Thompson
Maeve PascoeMaeve Pascoe
Maeve Pascoe
MFMaleeha Faisal
Maleeha Faisal
DMDouglas E. Moul
Douglas E. Moul
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
Study Objectives:Drowsy driving related to obstructive sleep apnea (OSA) represents an important public health problem with limited data on the effect of positive airway pressure (PAP) therapy. We ...

28 October 2024 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
Maeve PascoeMaeve Pascoe
Maeve Pascoe
EBEmma Byrne
Emma Byrne
AKAmanda King
Amanda King
DCDiane Cooper
Diane Cooper
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
TATerri Armstrong
Terri Armstrong
Background: Radiation is the standard-of-care treatment for primary brain tumors (PBTs) but may have profound effects on sleep that have not yet been fully characterized. This systematic review aims to further our understanding of radiation therapy on the risk of development of sleep disorders in patients with PBTs, as well as potential opportunities for prevention and treatment. Methods: A systematic search of PubMed, Embase, and Web of Science was performed (last Jan 2024) with predefined inclusion (PBT patients, radiation therapy, somnolence/circadian disruption) and exclusion (reviews/abstracts/cases/chapters, non-PBT cancer, lack of radiation) criteria, yielding 267 papers initially and 38 studies included. Data extraction and analysis (descriptive statistics, individual study summary) focused on the incidence of sleep disturbances, radiation types/doses, and pharmacologic interventions. Risk of bias assessment was conducted with the Effective Public Health Practice Project’s Quality Assessment Tool for Quantitative Studies. Results: The included 38 studies (n = 2948 patients) demonstrated a high incidence of sleep disturbances in patients with PBTs throughout radiation therapy, but primarily from the end of radiation to 6 months after. Sleep symptoms were associated with radiation (dose-dependent), and pharmacotherapies were helpful in patients with formal sleep disorder diagnoses. Terminology and incidence reporting of sleep symptoms are inconsistent, and many studies had a high risk of bias. Conclusions: This systematic review highlights the ongoing challenges with sleep symptoms/disorders related to cranial irradiation treatment in the primary brain tumor population. Further investigations on the interconnectedness of sleep disturbance constructs and possible pharmacotherapies to alleviate symptoms are warranted.

14 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSeetha Lakshmanan
Seetha Lakshmanan
NTNicolas R. Thompson
Nicolas R. Thompson
Maeve PascoeMaeve Pascoe
Maeve Pascoe
RMReena Mehra
Reena Mehra
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
HWHarneet Walia
Harneet Walia
Study Objective: Studies have shown increased prevalence of restless legs syndrome (RLS) in sleep disordered breathing (SDB), however limited data have focused on the impact of SDB therapy on RLS. We hypothesize that positive airway pressure (PAP) will improve the International Restless Legs Syndrome (IRLS) score among SDB patients compared to patients without PAP. Methods: Patients with AHI ≥ 5 who responded positively to a RLS qualifier question from January 2010 to May 2015 were included in this retrospective study. IRLS score was used to measure RLS symptom severity. Two-sample t-tests and one-way analysis of variance were used to compare changes in IRLS score and linear regression models were created to examine IRLS change with PAP use and PAP adherence (PAP usage ≥4 h nightly for ≥70% of nights), adjusting for potential confounders. Results: In 434 patients (51.9 ± 13.4years, 50.5% female, 77.6% Caucasian; 325 PAP, 109 control), IRLS scores improved from baseline to follow-up, with the PAP group achieving significant improvement after adjustment for covariates (difference in IRLS: −1.8 (CI −3.6,0.00), p = 0.050). In self-reported PAP adherent patients, IRLS improvement was greater than controls (−5.3 ± 7.4 vs. −2.7 ± 7.6 respectively, p = 0.045), and comparable to non-adherent patients (−5.3 ± 7.4 vs. −3.0 ± 7.0, p = 0.091). Conclusions: Among SDB patients with a positive RLS qualifier, those who used PAP therapy achieved significantly greater improvement in IRLS scores than patients who did not use PAP, with more significant changes in the PAP adherent group. This is the first large clinical study to examine these relationships, providing a basis for future prospective interventional trials and informing clinicians of expected improvement in IRLS score in PAP treated SDB populations.

24 May 2024 in Neuro-Oncology Practice
Verified
Journal Article
Closed access
Maeve PascoeMaeve Pascoe
Maeve Pascoe
AWAlex R Wollet
Alex R Wollet
JMJulianie De La Cruz Minyety
Julianie De La Cruz Minyety
EVElizabeth Vera
Elizabeth Vera
HMHope Miller
Hope Miller
TATerri Armstrong
Terri Armstrong
Background: Sleep–wake disturbances are common and disabling in primary brain tumor (PBT) patients but studies exploring longitudinal data are limited. This study investigates the feasibility and relationship between longitudinal patient-reported outcomes (PROs) and physiologic data collected via smart wearables. Methods: Fifty-four PBT patients ≥ 18 years wore Fitbit smart-wearable devices for 4 weeks, which captured physiologic sleep measures (eg, total sleep time, wake after sleep onset [WASO]). They completed PROs (sleep hygiene index, PROMIS sleep-related impairment [SRI] and Sleep Disturbance [SD], Morningness-Eveningness Questionnaire [MEQ]) at baseline and 4 weeks. Smart wearable use feasibility (enrollment/attrition, data missingness), clinical characteristics, test consistency, PROs severity, and relationships between PROs and physiologic sleep measures were assessed. Results: The majority (72%) wore their Fitbit for the entire study duration with 89% missing < 3 days, no participant withdrawals, and 100% PRO completion. PROMIS SRI/SD and MEQ were all consistent/reliable (Cronbach’s alpha 0.74–0.92). Chronotype breakdown showed 39% morning, 56% intermediate, and only 6% evening types. Moderate-severe SD and SRI were reported in 13% and 17% at baseline, and with significant improvement in SD at 4 weeks (P = .014). Fitbit-recorded measures showed a correlation at week 4 between WASO and SD (r = 0.35, P = .009) but not with SRI (r = 0.24, P = .08). Conclusions: Collecting sleep data with Fitbits is feasible, PROs are consistent/reliable, > 10% of participants had SD and SRI that improved with smart wearable use, and SD was associated with WASO. The skewed chronotype distribution, risk and impact of sleep fragmentation mechanisms warrant further investigation. Trial Registration: NCT04 669 574